TIDMCTEC
RNS Number : 3272M
ConvaTec Group PLC
07 May 2020
ConvaTec Group Plc
Results of Annual General Meeting
Reading, United Kingdom 7 May 2020 - Poll Result
ConvaTec Group Plc ("ConvaTec"), a leading global medical
products and technologies company, held its annual general meeting
today ("Meeting"), The results of the poll held in relation to the
resolutions proposed at the Meeting are set out below.
For Against Total Votes % of Number
(see note 2) (see note 2) ISC of Votes
Voted Withheld
(see note
3
Resolution No of shares % No of Shares %
-------------- ------- ------------- ------
Receive Annual
Report and
1 Accounts 1,689,253,478 99.99 162,424 0.01 1,689,415,902 85.17 1,375,861
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Approve the
Directors'
Remuneration
2 Report 1,459,271,427 86.35 230,658,135 13.65 1,689,929,562 85.20 908,684
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Approve the
Directors'
Remuneration
3 Policy 1,479,320,219 87.54 210,611,343 12.46 1,689,931,562 85.20 906,684
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Declare Final
4 Dividend 1,670,311,992 98.79 20,526,249 1.21 1,690,838,241 85.24 6
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Elect John
McAdam as
5 a director 1,686,038,868 99.72 4,725,844 0.28 1,690,764,712 85.24 73,534
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Elect Karim
Bitar as
6 a director 1,687,089,831 99.78 3,746,388 0.22 1,690,836,219 85.24 2,028
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Elect Brian
May as a
7 director 1,689,080,374 99.90 1,749,450 0.10 1,690,829,824 85.24 8,423
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Re-elect
Frank Schulkes
8 as a director 1,684,095,328 99.60 6,734,291 0.40 1,690,829,619 85.24 8,628
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Re-elect
Margaret
Ewing as
9 a director 1,662,219,417 98.31 28,611,702 1.69 1,690,831,119 85.24 7,128
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Re-elect
Rick Anderson
10 as a director 1,686,272,799 99.73 4,561,920 0.27 1,690,834,719 85.24 3,528
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Re-elect
Regina Benjamin
11 as a director 1,678,521,751 99.30 11,891,727 0.70 1,690,413,478 85.22 424,768
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Re-elect
Ros Rivaz
12 as a director 1,630,402,633 96.47 59,672,747 3.53 1,690,075,380 85.21 762,866
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Re-elect
Sten Scheibye
13 as a director 1,687,084,151 99.78 3,745,468 0.22 1,690,829,619 85.24 8,628
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Re-appoint
Deloitte
14 LLP as auditor 1,690,827,240 100.00 9,746 0.00 1,690,836,986 85.24 1,261
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Authorise
the directors
to determine
the remuneration
of the Company's
15 auditor 1,690,692,456 100.00 5,000 0.00 1,690,697,456 85.24 140,791
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Authorise
political
donations
and political
16 expenditure 1,679,778,558 99.35 11,050,957 0.65 1,690,829,515 85.24 8,732
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Authorise
allotment
17 of shares 1,576,731,448 93.28 113,598,212 6.72 1,690,329,660 85.22 508,587
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Disapply
pre-emption
18 rights* 1,665,615,258 98.53 24,844,432 1.47 1,690,459,690 85.23 378,557
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Disapply
pre-emption
rights in
connection
with an acquisition
or specified
19 capital investment* 1,664,010,440 98.44 26,449,249 1.56 1,690,459,689 85.23 378,557
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Authorise
purchase
20 of own shares* 1,669,151,425 98.76 20,937,729 1.24 1,690,089,154 85.21 749,092
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
Call general
meetings
on 14 days'
21 notice* 1,663,148,185 98.36 27,687,156 1.64 1,690,835,341 85.24 2,906
--------------------- -------------- ------- ------------- ------ -------------- ------- -----------
*Special Resolution
NOTES:
1. All resolutions were passed.
2. Votes "For" and "Against" are expressed as a percentage of votes received.
3. A "Vote withheld" is not a vote in law and is not counted in
the calculation of the votes "For" or "Against" a resolution.
4. Total number of shares in issue at close of business on 6 May
2020 was 1,983,513,851 shares; 85.24% of voting capital was
instructed.
5. Computershare acted as scrutineer of the poll on all resolutions.
In accordance with Listing Rule 9.6.2, copies of the resolutions
that do not constitute ordinary business that were passed at the
Meeting will be submitted to the National Storage Mechanism and
will be available for inspection at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism .
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on therapies for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. ConvaTec's
products provide a range of clinical and economic benefits
including infection prevention, protection of at-risk skin,
improved patient outcomes and reduced total cost of care. To learn
more about ConvaTec, please visit www.convatecgroup.com where a
copy of this announcement can also be found.
Enquiries
Analysts and Investors
Mark Reynolds, Director Investor Relations, ConvaTec +44 (0)7551 036 625
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane / Vicky Hayns +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
# # #
END
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGUBAVRRRUVRAR
(END) Dow Jones Newswires
May 07, 2020 11:15 ET (15:15 GMT)
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Convatec (LSE:CTEC)
Storico
Da Mar 2023 a Mar 2024